ONA Therapeutics
Dr. Clara Campàs is Managing Partner and founder at the venture capital firm Asabys Partners (Barcelona) since 2018. Formerly, she served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including managing director. Dr. Campàs has served as a member of the Investment Committee of the venture capital firm HealthEquity, as well as vice-president of CataloniaBIO and member of the Board of Directors of Biocat. She acted as a mentor in several programs such as BStartup, Caixaimpulse and MOEBIO. Up to 2006, Dr. Campàs was a researcher engaged in the development of new therapies in cancer. She received her Doctorate in Pharmacy and a Master’s in Pharmacy from the University of Barcelona.
This person is not in the org chart
This person is not in any teams
ONA Therapeutics
Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.